Ultime notizie per Moelis (NYSE:MC) Azioni

MOELIS & CO - CLASS A

Moelis

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Moelis & Co

Merit Circle - United States Dollar

Mountain & Co I Acquisition Corp Ordinary Shares - Class A

Mountain & Co I Acquisition Corp

Mountain & Co I Acquisition Corp Units (1 Ord Class A & 1/2 War)

Mountain & Co I Acquisition Corp Warrants - (04/11/2026)

MONTEREY CAP ACQUISITION CORP CL A

MONTEREY CAP ACQUISITION CORP RT

MONTEREY CAP ACQUISITION CORP UNIT 1 CL A & 1 RT & 1 WT

MONTEREY CAP ACQUISITION CORP WT EXP

Mountain Crest Acquisition Corp IV

MOUNTAIN CREST ACQUISITION CORP IV RT

Mountain Crest Acquisition Corp IV Units (1 Ordinary Shares& 1 Rights)

MOUNTAIN CREST ACQ V by Mountain Crest Acquisition Corp. V

Mountain Crest Acquisition Corp V

MOUNTAIN CREST ACQUISITION CORP V RT

Mountain Crest Acquisition Corp V Units (1 Ordinary Shares, 1 Rights)

MCAP Inc

Mercari Inc

Mcashchain

MacroAsia Corp

Metropolitan Bank Holding Corp. Common Stock

Metropolitan Bank Holding Corp

MCDEX Token

Macatawa Bank Corp. Com

MOUNTAIN COMM BANCORP INC by Mountain Commerce Bancorp Inc.

Mountain Commerce Bancorp Inc

MADISON COUNTY FINCL INC by Madison County Financial, Inc.

Madison County Financial Inc

MERHAV-CERMC & BLDG MTRLS by MERHAV-CERAMIC & BUILDING MATERIALS CENTER LTD.

Hamat Group Ltd

MICHIGAN COMMUTY BNCRP by Michigan Community Bancorp Ltd.

McBride PLC

MetroCity Bankshares, Inc. - Common Stock

MetroCity Bankshares Inc

MCCHIP RESOURCES INC by McChip Resources, Inc.

McChip Resources Inc

Mestek Inc

MCCOY GLOBAL INC ORD by McCoy Global, Inc.

McCoy Global Inc

MCX Technologies Corp

McDonald's Corp

KMA Holding Inc

McDermott International Ltd Warrants - Class B (30/06/2027)

McDermott International Ltd

McDermott International Ltd Ordinary Shares

MCDERMOTT INTL LTD by McDermott International LTD.

MACDONALD MINES EXPL LTD by MacDonald Mines Exploration Ltd.

MacDonald Mines Exploration Ltd

JPMorgan Fundamental Data Science Mid Core ETF

McDermott International Ltd Warrants - Class A (30/06/2027)

MILLENNIUM CELL INC by Millennium Cell, Inc.

Millennium Cell Inc

MONARCH CEMENT CO by Monarch Cement Co. (The)

Monarch Cement Co

MULTICELL TECHS INC by MultiCell Technologies, Inc.

MultiCell Technologies Inc

MCF Energy Ltd

MasterCraft Boat Holdings, Inc. - Common Stock

MasterCraft Boat Holdings Inc

Matthews International Funds Matthews China Active ETF

MATCHAAH HOLDING INC by Matchaah Holdings, Inc.

Matchaah Holdings Inc

MECHANICS BK RICHMOND CAL by Mechanics Bank of Richmond (CA)

Mechanics Bank

MACMAHON HOLDINGS LTD ORD by MacMahon Holdings Ltd.

Macmahon Holdings Ltd

iShares MSCI China ETF

MARUICHI STEEL TUBE LTD by Maruichi Steel Tube Ltd.

Maruichi Steel Tube Ltd

McHenry Bancorp Inc Com (New)

MULTICHOICE GROUP SP/ADR by MultiChoice Group Limited

MultiChoice Group Ltd

Microchip Technology Incorporated - Common Stock

Microchip Technology Inc

Microchip Technology Incorporated - Depositary Shares Each Representing a 1/20th Interest in a Share of 7.50% Series A Mandatory Convertible Preferred Stock

Matthews China Discovery Active ETF

M CASH INTEGRASI TBK ORD by M Cash Integrasi Tbk PT

MAUCH CHUNK TR FINCL CORP by Mauch Chunk Trust Financial Corp.

Mauch Chunk Trust Financial Corp

MGM CHINA HOLDINGS ORD by MGM China Holdings, Ltd.

MGM China Holdings Ltd

MGM CHINA HLDGS UNSP/ADR by MGM China Holdings, Ltd.

Marchex Inc

Barings Corporate Investors

MERCIA ASSET MGMT PLC by Mercia Asset Mgmt Plc

Mercia Asset Management PLC

MULTICORP INTL INC by Multicorp International, Inc.

MultiCorp International Inc

MACAU CAP INVSTS INC NEW by Macau Capital Investments, Inc.

Macau Capital Investments Inc

MCI Onehealth Technologies Inc Ordinary Shares - Class A (Sub Voting)

MCJ Co Ltd

McKesson Corp

MALLINCKRODT PB LTD CO by Mallinckrodt plc.

Jade Leader Corp

MORSES CLUB PLC by MORSES CLUB PLC

MCLOUD TECHNOLOGIES INC by MCLOUD TECHNOLOGIES CORP.

mCloud Technologies Corp

Medicale Corp

MCLOUD TECHS CORP 9 PFD A by MCLOUD TECHNOLOGIES CORP.

mCloud Technologies Corp Warrants (29/11/2026)

XAI Madison Equity Premium Income Fund Common Shares

XAI Madison Equity Premium Income Fund

Macnica Holdings Inc

MUCINNO HOLDING INC by Mucinno Holding, Inc.

Mucinno Holding Inc

MILLENNIUM & CPTHRNE HTLS by Millennium & Copthorne Hotels New Zealand Ltd.

Millennium & Copthorne Hotels New Zealand Ltd

Moodys Corp

MCO - United States Dollar

Moss Carbon Credit - United States Dollar

MARIJUANA CO OF AMER INC by Marijuana Company of America, Inc.

Marijuana Company of America Inc

MULTICHOICE GROUP LIMITED by MultiChoice Group Limited

MICROMOBILITY.COM INC A by Micromobility.com Inc.

Micromobility com Inc

Micromobility com Inc Warrants (28/10/2024)

MT CARMEL PUBLIC UTIL CO by Mt. Carmel Public Utility Co.

Mount Carmel Public Utility Co

Midland Capital Holdings Corp Com

MOCHIDA PHARM CO LTD by Mochida Pharmaceutical Co., Ltd.

Mochida Pharmaceutical Co Ltd

MACQUARIE GRP LTD by Macquarie Group, Ltd.

Macquarie Group Ltd

MFS Charter Income Trust

MCRAE INDUS INC A by McRae Industries, Inc.

McRae Industries Inc

MCRAE INDUS INC B by McRae Industries, Inc.

Seres Therapeutics Inc

MICROPORT CRDFLW MD U/ADR by MICROPORT CARDIOFLOW MEDTECH CORP.

MicroPort CardioFlow Medtech Corp

METALS CREEK RES by Metals Creek Resources Corp.

Metals Creek Resources Corp

Monarch Casino & Resort, Inc. - Common Stock

Monarch Casino & Resort Inc

MICRO-MECHANICS LTD ORD by Micro-Mechanics Ltd.

Micro-Mechanics (Holdings) Ltd

Micropolis Holding Company Ordinary Shares

Micropolis Holding Co

MICROPORT SCIENTIFIC CORP by Microport Scientific Corp.

MicroPort Scientific Corp

WIIM

ARES

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BRDG

EMCG

FRHC

FUTU

HLNE

HOOD

IBKR

Janus Henderson Group plc Ordinary Shares

LPLA

LPRO

MKTW

NDAQ

NTRS

PIPR

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

SCHW

SNEX

SPGI

STEP

TROW

Shares of capital market companies are trading lower as markets react to President Trump's announcement of sweeping tariffs.

Moelis's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) short percent of float has risen 38.94% since its last report. The company recently reported that it has 3.84 million shares sold short, which is 8.1% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.43 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Moelis Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742328921_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Moelis has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Moelis's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Moelis's peer group average for short interest as a percentage of float is 3.03%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

What's Driving the Market Sentiment Around Moelis?

Goldman Sachs analyst James Yaro maintains Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) with a Neutral and lowers the price target from $86 to $75.

News

Price Target

Analyst Ratings

Goldman Sachs Maintains Neutral on Moelis, Lowers Price Target to $75

Analysts' ratings for Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) over the last quarter vary from bullish to bearish, as provided by 7 analysts.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $85.0, with a high estimate of $100.00 and a low estimate of $70.00. This current average reflects an increase of 1.54% from the previous average price target of $83.71. 
<img src="https://www.benzinga.com/files/images/story/2025/1741874483_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
The standing of Moelis among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$70.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>James Yaro</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Neutral</td>
<td>$87.00</td>
<td>$79.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$92.00</td>
<td>$86.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Equal-Weight</td>
<td>$83.00</td>
<td>$77.00</td>
</tr>
<tr>
<td>Ryan Kenny</td>
<td>Morgan Stanley</td>
<td>Raises</td>
<td>Overweight</td>
<td>$100.00</td>
<td>$95.00</td>
</tr>
<tr>
<td>Michael Brown</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$77.00</td>
<td>$78.00</td>
</tr>
<tr>
<td>Aidan Hall</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$86.00</td>
<td>$71.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Moelis. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Moelis compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Moelis's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Moelis's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/MC/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Moelis analyst ratings.</a>
<h2>Unveiling the Story Behind Moelis</h2>
Moelis &amp; Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.
<h3>Moelis: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Over the 3 months period, Moelis showcased positive performance, achieving a revenue growth rate of 104.17% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Financials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 20.38%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Moelis's ROE excels beyond industry benchmarks, reaching 22.1%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): Moelis's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.06% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Moelis's debt-to-equity ratio is below the industry average. With a ratio of 0.51, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Beyond their standard evaluations, some analysts contribute predictions for metrics like growth estimates, earnings, and revenue, furnishing investors with additional guidance. Users of analyst ratings should be mindful that this specialized advice is shaped by human perspectives and may be subject to variability.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Beyond The Numbers: 7 Analysts Discuss Moelis Stock

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>B of A Securities analyst Brad Sills downgraded the rating for UiPath Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) from Neutral to Underperform and lowered the price target from $18 to $10. UiPath shares closed at $11.83 on Wednesday. <a href="https://www.benzinga.com/quote/path/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Morgan Stanley analyst Ryan Kenny downgraded Moelis &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) from Overweight to Underweight and lowered the price target from $100 to $70. Moelis shares closed at $60.09 on Wednesday. <a href="https://www.benzinga.com/quote/mc/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham analyst David Saxon downgraded the rating for DENTSPLY SIRONA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XRAY#NASDAQ">XRAY</a>) from Buy to Hold. Dentsply Sirona shares closed at $15.33 on Wednesday. <a href="https://www.benzinga.com/quote/XRAY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Truist Securities analyst Ki Bin Kim downgraded Federal Realty Investment Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FRT#NYSE">FRT</a>) from Buy to Hold and lowered the price target from $114 to $105. Federal Realty Investment shares closed at $97.12 on Wednesday. <a href="https://www.benzinga.com/quote/FRT/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham analyst David Saxon downgraded the rating for ZimVie Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZIMV#NASDAQ">ZIMV</a>) from Buy to Hold. ZimVie shares closed at $12.65 on Wednesday. <a href="https://www.benzinga.com/quote/ZIMV/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying PATH stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="595" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13080714/image-103-1024x595.png" alt="" class="wp-image-822803" style="width:585px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13080714/image-103-1024x595.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13080714/image-103-300x174.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13080714/image-103-768x446.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/13080714/image-103.png 1121w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/25/03/44295828/adobe-intel-and-3-stocks-to-watch-heading-into-thursday">Adobe, Intel And 3 Stocks To Watch Heading Into Thursday</a></li>
</ul>

Downgrades

Pre-Market Outlook

Markets

PATH

XRAY

ZIMV

This UiPath Analyst Turns Bearish; Here Are Top 5 Downgrades For Thursday

Morgan Stanley analyst Ryan Kenny downgrades Moelis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MC#NYSE">MC</a>) from Overweight to Underweight and lowers the price target from $100 to $70.

Comments

Moelis

Notizie

Ultime notizie per Moelis (NYSE:MC) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO